Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

Brian A Ference, Christopher P Cannon, Ulf Landmesser, Thomas F Lüscher, Kausik K Ray, Alberico Luigi Catapano

Research output: Contribution to journalArticle

Original languageEnglish
JournalEuropean Heart Journal
DOIs
Publication statusE-pub ahead of print - Aug 14 2017

Cite this

@article{7dee256d55ce432e81235e3fa71d3fcc,
title = "Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration",
author = "Ference, {Brian A} and Cannon, {Christopher P} and Ulf Landmesser and L{\"u}scher, {Thomas F} and Ray, {Kausik K} and Catapano, {Alberico Luigi}",
year = "2017",
month = "8",
day = "14",
doi = "10.1093/eurheartj/ehx450",
language = "English",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins

T2 - an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

AU - Ference, Brian A

AU - Cannon, Christopher P

AU - Landmesser, Ulf

AU - Lüscher, Thomas F

AU - Ray, Kausik K

AU - Catapano, Alberico Luigi

PY - 2017/8/14

Y1 - 2017/8/14

U2 - 10.1093/eurheartj/ehx450

DO - 10.1093/eurheartj/ehx450

M3 - Article

C2 - 29020411

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

ER -